Liver extracellular vesicles in health and disease

References

• Shirakami Y, Lee SA, Clugston RD, Blaner WS. Hepatic metabolism of retinoids and disease associations. 2012, 1821: 124-36. 10.3402/jev.v1i0.18825.
   Google Scholar
• Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. 2008, 48: 322-35. 10.3402/jev.v1i0.18825.
   Google Scholar
• Moreira RK. Hepatic stellate cells and liver fibrosis. 2007, 131: 1728-34.
   Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. 2010, 73: 1907-20. 10.3402/jev.v1i0.18825.
   Google Scholar
• Falcon-Perez JM, Lu SC, Mato JM. Sub-proteome approach to the knowledge of liver. 2010, 4: 407-15. 10.3402/jev.v1i0.18825.
   Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. 2009, 19: 43-51. 10.3402/jev.v1i0.18825.
   Google Scholar
• Simons M, Raposo G. Exosomes – vesicular carriers for intercellular communication. 2009, 21: 575-81. 10.3402/jev.v1i0.18825.
   Google Scholar
• Bastida E, Ordinas A, Escolar G, Jamieson GA. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. 1984, 64: 177-84.
   Google Scholar
• Tan F, Zhang Y, Mi W, Wang J, Wei J, Cai Yet al.Enrichment of phosphopeptides by Fe3 + -immobilized magnetic nanoparticles for phosphoproteome analysis of the plasma membrane of mouse liver. 2008, 7: 1078-87. 10.3402/jev.v1i0.18825.
   Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. 2007, 9: 654-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• Duijvesz D, Luider T, Bangma CH, Jenster G. Exosomes as biomarker treasure chests for prostate cancer. 2011, 59: 823-31. 10.3402/jev.v1i0.18825.
   Google Scholar
• Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. 2009, 10: 42-6. 10.3402/jev.v1i0.18825.
   Google Scholar
• Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E, Berisa A, Gil D, Embade Net al.Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. 2010, 4: 416-25. 10.3402/jev.v1i0.18825.
   Google Scholar
• Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). 2000, 32: 477-81. 10.3402/jev.v1i0.18825.
   Google Scholar
• Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert Eet al.Sampling variability of liver biopsy in nonalcoholic fatty liver disease. 2005, 128: 1898-906. 10.3402/jev.v1i0.18825.
   Google Scholar
• Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle Met al.Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. 2008, 7: 5157-66. 10.3402/jev.v1i0.18825.
   Google Scholar
• Conde-Vancells J, Gonzalez E, Lu SC, Mato JM, Falcon-Perez JM. Overview of extracellular microvesicles in drug metabolism. 2010, 6: 543-54. 10.3402/jev.v1i0.18825.
   Google Scholar
• Butler SL, Dong H, Cardona D, Jia M, Zheng R, Zhu Het al.The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. 2008, 88: 78-88. 10.3402/jev.v1i0.18825.
   Google Scholar
• Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure Aet al.Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. 2009, 23: 1643-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann Wet al.Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. 2005, 4: 1595-604. 10.3402/jev.v1i0.18825.
   Google Scholar
• Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. 2003, 63: 4331-7.
   Google Scholar
• Fleissner F, Goerzig Y, Haverich A, Thum T. Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. 2012, 12: 289-97. 10.3402/jev.v1i0.18825.
   Google Scholar
• Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella Det al.Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. 2010, 14: 1605-18. 10.3402/jev.v1i0.18825.
   Google Scholar
• Wetmore BA, Brees DJ, Singh R, Watkins PB, Andersen ME, Loy Jet al.Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. 2010, 51: 2127-39. 10.3402/jev.v1i0.18825.
   Google Scholar
• Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. 2005, 41: 380-2. 10.3402/jev.v1i0.18825.
   Google Scholar
• Nosaka K. Changes in serum enzyme activities after injection of bupivacaine into rat tibialis anterior. 1996, 81: 876-84.
   Google Scholar
• Kudo Y, Ochi T, Shimada H, Ogawa S, Shinjo K. Utility of plasma circulating mRNA as a marker to detect hepatic injury. 2008, 70: 993-5. 10.3402/jev.v1i0.18825.
   Google Scholar
• Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone Let al.Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. 2007, 110: 2440-8. 10.3402/jev.v1i0.18825.
   Google Scholar
• Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. 2004, 6: 532-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• Aliotta JM, Pereira M, Johnson KW, de Paz N, Dooner MS, Puente Net al.Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. 2010, 38: 233-45. 10.3402/jev.v1i0.18825.
   Google Scholar
• Asselah T, Benhamou Y, Marcellin P. Protease and polymerase inhibitors for the treatment of hepatitis C. 2009, 29Suppl 157-67. 10.3402/jev.v1i0.18825.
   Google Scholar
• Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk Bet al.Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. 2007, 446: 801-5. 10.3402/jev.v1i0.18825.
   Google Scholar
• Murray CL, Jones CT, Rice CM. Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. 2008, 6: 699-708. 10.3402/jev.v1i0.18825.
   Google Scholar
• Burlone ME, Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. 2009, 90Pt 51055-70. 10.3402/jev.v1i0.18825.
   Google Scholar
• Chen BJ, Lamb RA. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT?. 2008, 372: 221-32. 10.3402/jev.v1i0.18825.
   Google Scholar
• Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. 2002, 3: 321-30. 10.3402/jev.v1i0.18825.
   Google Scholar
• Hanson PI, Shim S, Merrill SA. Cell biology of the ESCRT machinery. 2009, 21: 568-74. 10.3402/jev.v1i0.18825.
   Google Scholar
• Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, Brunetto Met al.Association of hepatitis C virus envelope proteins with exosomes. 2004, 34: 2834-42. 10.3402/jev.v1i0.18825.
   Google Scholar
• Tamai K, Tanaka N, Nara A, Yamamoto A, Nakagawa I, Yoshimori Tet al.Role of Hrs in maturation of autophagosomes in mammalian cells. 2007, 360: 721-7. 10.3402/jev.v1i0.18825.
   Google Scholar
• Tamai K, Shiina M, Tanaka N, Nakano T, Yamamoto A, Kondo Yet al.Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway. 2012, 422: 377-85. 10.3402/jev.v1i0.18825.
   Google Scholar
• Fausto N, Campbell JS, Riehle KJ. Liver regeneration. 2006, 432 Suppl 1S45-53. 10.3402/jev.v1i0.18825.
   Google Scholar
• Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. 2007, 39: 695-714. 10.3402/jev.v1i0.18825.
   Google Scholar
• Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak Pet al.Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. 2006, 20: 847-56. 10.3402/jev.v1i0.18825.
   Google Scholar
• Quesenberry PJ, Aliotta JM. The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. 2008, 4: 137-47. 10.3402/jev.v1i0.18825.
   Google Scholar
• Witek RP, Yang L, Liu R, Jung Y, Omenetti A, Syn WKet al.Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. 2009, 136: 320-30.e2. 10.3402/jev.v1i0.18825.
   Google Scholar
• Huang BQ, Masyuk TV, Muff MA, Tietz PS, Masyuk AI, Larusso NF. Isolation and characterization of cholangiocyte primary cilia. 2006, 291: G500-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• Masyuk AI, Huang BQ, Ward CJ, Gradilone SA, Banales JM, Masyuk TVet al.Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. 2010, 299: G990-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• Lee SO, Masyuk T, Splinter P, Banales JM, Masyuk A, Stroope Aet al.MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. 2008, 118: 3714-24. 10.3402/jev.v1i0.18825.
   Google Scholar
• Friedman SL. Liver fibrosis – from bench to bedside. 2003, 38Suppl 1S38-53. 10.3402/jev.v1i0.18825.
   Google Scholar
• Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. 2004, 350: 1646-54. 10.3402/jev.v1i0.18825.
   Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. 2002, 2: 569-79.
   Google Scholar
• Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. 2002, 3: 1156-62. 10.3402/jev.v1i0.18825.
   Google Scholar
• Sadallah S, Eken C, Schifferli JA. Ectosomes as modulators of inflammation and immunity. 2011, 163: 26-32. 10.3402/jev.v1i0.18825.
   Google Scholar
• Mastronardi ML, Mostefai HA, Meziani F, Martinez MC, Asfar P, Andriantsitohaina R. Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. 2011, 39: 1739-48. 10.3402/jev.v1i0.18825.
   Google Scholar
• Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier Cet al.Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. 2001, 7: 297-303. 10.3402/jev.v1i0.18825.
   Google Scholar
• Brodsky SV, Facciuto ME, Heydt D, Chen J, Islam HK, Kajstura Met al.Dynamics of circulating microparticles in liver transplant patients. 2008, 17: 261-8.
   Google Scholar
• Locke JA, Fazli L, Adomat H, Smyl J, Weins K, Lubik AAet al.A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer. 2009, 69: 928-37. 10.3402/jev.v1i0.18825.
   Google Scholar
• Crispe IN. The liver as a lymphoid organ. 2009, 27: 147-63. 10.3402/jev.v1i0.18825.
   Google Scholar
• Pradere JP, Troeger JS, Dapito DH, Mencin AA, Schwabe RF. Toll-like receptor 4 and hepatic fibrogenesis. 2010, 30: 232-44. 10.3402/jev.v1i0.18825.
   Google Scholar
• Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell ME, Apovian CMet al.Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. 2008, 16: 932-7. 10.3402/jev.v1i0.18825.
   Google Scholar
• Deng ZB, Liu Y, Liu C, Xiang X, Wang J, Cheng Zet al.Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. 2009, 50: 1412-20. 10.3402/jev.v1i0.18825.
   Google Scholar
• Croce CM. Causes and consequences of microRNA dysregulation in cancer. 2009, 10: 704-14. 10.3402/jev.v1i0.18825.
   Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. 2008, 110: 13-21. 10.3402/jev.v1i0.18825.
   Google Scholar
• Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves Met al.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. 2008, 10: 1470-6. 10.3402/jev.v1i0.18825.
   Google Scholar
• Kogure T, Lin WL, Yan IK, Braconi C, Patel T. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. 2011, 54: 1237-48. 10.3402/jev.v1i0.18825.
   Google Scholar
• Inokuchi S, Aoyama T, Miura K, Osterreicher CH, Kodama Y, Miyai Ket al.Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. 2010, 107: 844-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• Malato Y, Willenbring H. The MAP3K TAK1: a chock block to liver cancer formation. 2010, 52: 1506-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• Fujiki T, Miura T, Maura M, Shiraishi H, Nishimura S, Imada Yet al.TAK1 represses transcription of the human telomerase reverse transcriptase gene. 2007, 26: 5258-66. 10.3402/jev.v1i0.18825.
   Google Scholar
• Shetty S, Lalor PF, Adams DH. Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. 2008, 254: 136-46. 10.3402/jev.v1i0.18825.
   Google Scholar
• Edwards S, Lalor PF, Nash GB, Rainger GE, Adams DH. Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes. 2005, 41: 451-9. 10.3402/jev.v1i0.18825.
   Google Scholar
• van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JGet al.Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. 2008, 48: 449-57. 10.3402/jev.v1i0.18825.
   Google Scholar